{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:14:01Z","timestamp":1792286041365,"version":"4.4.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neuroscience.2024.12.059","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T12:24:38Z","timestamp":1735647878000},"page":"45-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Statins for vascular dementia: A hype or hope"],"prefix":"10.1016","volume":"567","author":[{"given":"Hussein A.","family":"Rajab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5221-4666","authenticated-orcid":false,"given":"Mustafa M.","family":"Shokr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser A.","family":"Al-Harchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubarak","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.12.059_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113257","article-title":"Brain injury-induced dysfunction of the blood brain barrier as a risk for dementia","volume":"328","author":"Abrahamson","year":"2020","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jacl.2020.10.007","article-title":"Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies","volume":"15","author":"Adhikari","year":"2021","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.720715","article-title":"Vascular dementia and underlying sex differences","volume":"13","author":"Akhter","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0020","author":"Al-kuraishy","year":"2020","journal-title":"Erectile Dysfunction and Statins: the Assorted View of Preponderance."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/0976-0105.195080","article-title":"Effects of rosuvastatin alone or in combination with omega-3 fatty acid on adiponectin levels and cardiometabolic profile","volume":"8","author":"Al-Kuraishy","year":"2016","journal-title":"J Basic Clin Pharm."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/0974-2727.208263","article-title":"Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: role of statins","volume":"9","author":"Al-Kuraishy","year":"2017","journal-title":"J Lab Physicians."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/jnrp.jnrp_97_18","article-title":"Lipoprotein-associated phospholipase A2 is linked with poor cardio-metabolic profile in patients with ischemic stroke: a study of effects of statins","volume":"9","author":"Alkuraishy","year":"2018","journal-title":"J Neurosci Rural Pract."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/japtr.JAPTR_18_20","article-title":"Metformin and\/or vildagliptin mitigate type II diabetes mellitus induced-oxidative stress: the intriguing effect","volume":"11","author":"Al-Kuraishy","year":"2020","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/IJCIIS.IJCIIS_7_20","article-title":"Statin therapy associated with decreased neuronal injury measured by serum S100beta levels in patients with acute ischemic stroke","volume":"11","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/IJCIIS.IJCIIS_49_20","article-title":"Statin therapy improves serum Annexin A1 levels in patients with acute coronary syndrome: a case-controlled study","volume":"11","author":"Al-Kuraishy","year":"2021","journal-title":"Int. J. Crit. Illn. Inj. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0055","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4103\/0028-3886.333482","article-title":"Statins Therapy improves acute ischemic stroke in patients with cardio-metabolic disorders measured by lipoprotein-associated phospholipase A2 (Lp-PLA2): new focal point","volume":"69","author":"Al-Kuraishy","year":"2021","journal-title":"Neurol. India"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0060","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s10753-022-01648-7","article-title":"The Prospective effect of allopurinol on the oxidative stress index and endothelial dysfunction in Covid-19","volume":"45","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102084","article-title":"The link between metabolic syndrome and Alzheimer disease: a mutual relationship and long rigorous investigation","volume":"91","author":"Al-Kuraishy","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0070","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s10787-023-01240-x","article-title":"The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s11064-022-03817-4","article-title":"A potential link between visceral obesity and risk of Alzheimer's disease","volume":"48","author":"Al-Kuraishy","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1422912","article-title":"The role of statins in amyotrophic lateral sclerosis: protective or not?","volume":"18","author":"Al-Kuraishy","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102209","article-title":"New insight on the possible role of statins in Vascular Parkinsonism: a need for presumptive therapy","volume":"95","author":"Al-Kuraishy","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"Suppl 8","key":"10.1016\/j.neuroscience.2024.12.059_b0090","article-title":"Intercellular adhesive molecule 1(ICAM-1) and acute ischaemic stroke: role of statins","volume":"71","author":"Al-Rubiay","year":"2021","journal-title":"J. Pak. Med. Assoc."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.059_b0095","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/sms.14193","article-title":"Statins effect on insulin resistance after a meal and exercise in hypercholesterolemic pre-diabetic individuals","volume":"32","author":"Alvarez-Jimenez","year":"2022","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-2012-120064","article-title":"Lipid lowering agents, cognitive decline, and dementia: the three-city study","volume":"30","author":"Ancelin","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.059_b0105","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/1440-1681.13508","article-title":"Pentoxifylline prevents epileptic seizure via modulating HMGB1\/RAGE\/TLR4 signalling pathway and improves memory in pentylenetetrazol kindling rats","volume":"48","author":"Badawi","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176851","article-title":"Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats","volume":"980","author":"Badawi","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/biof.1597","article-title":"The effects of statins on microglial cells to protect against neurodegenerative disorders: a mechanistic review","volume":"46","author":"Bagheri","year":"2020","journal-title":"Biofactors"},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.059_b0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.exger.2012.07.002","article-title":"Pharmacological prevention and treatment of vascular dementia: approaches and perspectives","volume":"47","author":"Baskys","year":"2012","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-2010-100180","article-title":"Statins and cognitive functioning in the elderly: a population-based study","volume":"21","author":"Benito-Leon","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/JAD-2009-1041","article-title":"Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology","volume":"17","author":"Bennett","year":"2009","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0135","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.002","article-title":"Statins, risk of dementia, and cognitive function: secondary analysis of the ginkgo evaluation of memory study","volume":"21","author":"Bettermann","year":"2012","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0140","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(00)04187-8","article-title":"Dementia and statins","author":"Birkenhager","year":"2001","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.059_b0145","article-title":"Role of oxidative damage in Alzheimer's disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery","volume":"10","author":"Buccellato","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0150","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s12640-020-00222-z","article-title":"Simvastatin prevents long-term cognitive deficits in sepsis survivor rats by reducing neuroinflammation and neurodegeneration","volume":"38","author":"Catalao","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/309507","article-title":"Systemic oxidative stress and conversion to dementia of elderly patients with mild cognitive impairment","volume":"2014","author":"Cervellati","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/jnc.13240","article-title":"Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study","volume":"135","author":"Cervellati","year":"2015","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11357-018-0010-6","article-title":"Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia","volume":"40","author":"Cervellati","year":"2018","journal-title":"Geroscience."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0170","article-title":"Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0175","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1038\/s41598-018-24248-8","article-title":"Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis","volume":"8","author":"Chu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.687585","article-title":"Hydrophilic or lipophilic statins?","volume":"8","author":"Climent","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","article-title":"Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study","volume":"71","author":"Cramer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0190","article-title":"The blood brain barrier dysfunction in healthy aging and dementia: why, how, what for?","volume":"102395","author":"Cunha","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0195","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s12035-020-02232-6","article-title":"Cholesterol metabolism in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"58","author":"Dai","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0200","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1734-1140(10)70339-X","article-title":"Memory restorative role of statins in experimental dementia: an evidence of their cholesterol dependent and independent actions","volume":"62","author":"Dalla","year":"2010","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0205","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-200541","article-title":"High cholesterol diet exacerbates blood-brain barrier disruption in LDLr-\/- mice: impact on cognitive function","volume":"78","author":"de Oliveira","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107614","article-title":"Statins and autoimmunity: state-of-the-art","volume":"214","author":"Dehnavi","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.059_b0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s40265-021-01510-4","article-title":"Targeting AMPK by statins: a potential therapeutic approach","volume":"81","author":"Dehnavi","year":"2021","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.neuroscience.2024.12.059_b0220","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1042\/CS20150351","article-title":"LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention","volume":"129","author":"Dias","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/STROKEAHA.112.670844","article-title":"Prevalence of poststroke cognitive impairment: South London Stroke Register 1995-2010","volume":"44","author":"Douiri","year":"2013","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.059_b0230","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1007\/s12035-016-0051-8","article-title":"Neuroprotective effects of simvastatin and Cilostazol in L-methionine-induced vascular dementia in rats","volume":"54","author":"El-Dessouki","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109711","article-title":"Neuroprotection impact of biochanin A against pentylenetetrazol-kindled mice: targeting NLRP3 inflammasome\/TXNIP pathway and autophagy modulation","volume":"115","author":"El-Sayed","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109986","article-title":"Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson's disease in rats: Correlation between Nrf2 and HMGB1\/TLR4\/PI3K\/Akt\/mTOR signaling","volume":"117","author":"El-Sayed","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0245","doi-asserted-by":"crossref","DOI":"10.1177\/20406223231171549","article-title":"Predictive value of hypercholesterolemia, vegetarian diet, and hypertension for incident dementia among elderly Taiwanese individuals with low educational levels","volume":"14","author":"Fan","year":"2023","journal-title":"Ther Adv Chronic Dis."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112502","article-title":"Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60-75 years?","volume":"383","author":"Fard","year":"2020","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116662","article-title":"Mixed dementia: Neglected clinical entity or nosographic artifice?","volume":"410","author":"Fierini","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2024.12.059_b0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2007.08.041","article-title":"Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease\/vascular dementia","volume":"266","author":"Gackowski","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13195-017-0237-y","article-title":"Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease","volume":"9","author":"Geifman","year":"2017","journal-title":"Alzheimers Res. Ther."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0270","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/000331970505600610","article-title":"N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke","volume":"56","author":"Giannakoulas","year":"2005","journal-title":"Angiology"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0275","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-220382","article-title":"Dementia risk reduction in primary care: a scoping review of clinical guidelines using a behavioral specificity framework","volume":"89","author":"Godbee","year":"2022","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0280","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/WAD.0b013e318188e80d","article-title":"Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with alzheimer disease","volume":"22","author":"Goldstein","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","article-title":"Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study","volume":"80","author":"Haag","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12916-017-0793-9","article-title":"Translational models for vascular cognitive impairment: a review including larger species","volume":"15","author":"Hainsworth","year":"2017","journal-title":"BMC Med."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2024.12.059_b0295","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ggi.12659","article-title":"Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients","volume":"15","author":"Hatanaka","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0300","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative G. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7-22 doi: 10.1016\/S0140-6736(02)09327-3.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.059_b0305","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.neurol.2023.02.071","article-title":"Impact of previous statin use on first intracerebral hemorrhage in cerebral amyloid angiopathy","volume":"179","author":"Helven","year":"2023","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.688090","article-title":"Blood-brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia","volume":"15","author":"Hussain","year":"2021","journal-title":"Front. Neurosci."},{"issue":"Suppl 8","key":"10.1016\/j.neuroscience.2024.12.059_b0315","article-title":"Statins and Covid-19: the Neglected Front of bidirectional effects","volume":"71","author":"Hussien","year":"2021","journal-title":"J. Pak. Med. Assoc."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0320","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22953","article-title":"Genetic mutations of APOEepsilon4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease","volume":"36","author":"Jabeen","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4066\/AMJ.2015.2014","article-title":"Statins and memory loss: an Australian experience","volume":"8","author":"Jamolowicz","year":"2015","journal-title":"Australas Med J"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.968039","article-title":"Statins and cognition: Modifying factors and possible underlying mechanisms","volume":"14","author":"Jamshidnejad-Tosaramandani","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"9242","key":"10.1016\/j.neuroscience.2024.12.059_b0335","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(00)03155-X","article-title":"Statins and the risk of dementia","volume":"356","author":"Jick","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.059_b0340","article-title":"The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future perspectives","volume":"11","author":"Jurcau","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0345","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/denthyp.denthyp_60_19","article-title":"Possible role of statins on the inflammatory biomarkers in patients with periodontal disease: a cross-sectional study","volume":"10","author":"Kadhim","year":"2019","journal-title":"Dental Hypotheses."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0355","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-014-0169-8","article-title":"Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease","volume":"2","author":"Kaiser","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8020030","article-title":"Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease","volume":"8","author":"Kim","year":"2020","journal-title":"Biomedicines."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","article-title":"Statins and inflammation: new therapeutic opportunities in psychiatry","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Psych."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0370","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01654-4","article-title":"Statin effects on cholesterol micro-domains in brain plasma membranes","volume":"65","author":"Kirsch","year":"2003","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.059_b0375","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1161\/STROKEAHA.107.481879","article-title":"Cerebral vascular dysfunction during hypercholesterolemia","volume":"38","author":"Kitayama","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0380","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2210-8-14","article-title":"Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats","volume":"8","author":"Koladiya","year":"2008","journal-title":"BMC Pharmacol."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1179\/1743132812Y.0000000127","article-title":"Atorvastatin and pitavastatin reduce oxidative stress and improve IR\/LDL-R signals in Alzheimer's disease","volume":"35","author":"Kurata","year":"2013","journal-title":"Neurol. Res."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.059_b0390","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jalz.2018.06.3061","article-title":"Stroke and dementia risk: a systematic review and meta-analysis","volume":"14","author":"Kuzma","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.727590","article-title":"Neurovascular alterations in vascular dementia: emphasis on risk factors","volume":"13","author":"Lecordier","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.059_b0400","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/mp.2014.81","article-title":"HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer's disease in a three cohorts study","volume":"20","author":"Leduc","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0405","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/joim.13134","article-title":"Statin exposure and the risk of dementia in individuals with hypercholesterolaemia","volume":"288","author":"Lee","year":"2020","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0410","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020446","article-title":"Inflammation and rho-associated protein kinase-induced brain changes in vascular dementia","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0415","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/ana.21053","article-title":"Simvastatin enhances learning and memory independent of amyloid load in mice","volume":"60","author":"Li","year":"2006","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.059_b0420","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/01.WNL.0000142963.90204.58","article-title":"Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study","volume":"63","author":"Li","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.059_b0425","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1532-5415.2010.02906.x","article-title":"Age-varying association between statin use and incident Alzheimer's disease","volume":"58","author":"Li","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0430","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/jnc.15456","article-title":"Do glia provide the link between low-grade systemic inflammation and normal cognitive ageing? A (1) H magnetic resonance spectroscopy study at 7 tesla","volume":"159","author":"Lind","year":"2021","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0435","first-page":"1885","article-title":"Simvastatin ameliorates cognitive impairments via inhibition of oxidative stress\u2011induced apoptosis of hippocampal cells through the ERK\/AKT signaling pathway in a rat model of senile dementia","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0440","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jocn.2022.11.016","article-title":"Peripheral high levels of CRP predict progression from normal cognition to dementia: a systematic review and meta-analysis","volume":"107","author":"Long","year":"2023","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0445","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cpt.2337","article-title":"Effect of SLCO1B1 T521C on statin-related myotoxicity with use of lovastatin and atorvastatin","volume":"110","author":"Lu","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"issue":"22","key":"10.1016\/j.neuroscience.2024.12.059_b0450","first-page":"2050","article-title":"Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia","volume":"8","author":"Ma","year":"2013","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0455","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s42003-021-02754-2","article-title":"Statin-mediated disruption of Rho GTPase prenylation and activity inhibits respiratory syncytial virus infection","volume":"4","author":"Malhi","year":"2021","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0460","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1874609812666190917155400","article-title":"Cholesterol and Dementia: a long and complicated relationship","volume":"13","author":"McFarlane","year":"2020","journal-title":"Curr. Aging Sci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0465","article-title":"Statins for the treatment of dementia","volume":"7","author":"McGuinness","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0470","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/ciia.2006.1.3.229","article-title":"Vascular dementia: prevention and treatment","volume":"1","author":"McVeigh","year":"2006","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0475","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.10-3065","article-title":"Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill","volume":"140","author":"Morandi","year":"2011","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.neuroscience.2024.12.059_b0480","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10120961","article-title":"The association between the usage of non-steroidal anti-inflammatory drugs and cognitive status: analysis of longitudinal and cross-sectional studies from the global Alzheimer's association interactive network and transcriptomic data","volume":"10","author":"Morris","year":"2020","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0485","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1447-0594.2009.00579.x","article-title":"Alzheimer's Society Vascular Dementia Systematic Review G. Systematic review of statins for the prevention of vascular dementia or dementia","volume":"10","author":"Muangpaisan","year":"2010","journal-title":"Geriatr. Gerontol. Int."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0490","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7715","article-title":"Association of familial hypercholesterolemia and statin use with risk of dementia in Norway","volume":"5","author":"Mundal","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"22","key":"10.1016\/j.neuroscience.2024.12.059_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228745","article-title":"The role of structure and biophysical properties in the pleiotropic effects of statins","volume":"21","author":"Murphy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0500","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0505","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fnagi.2020.00185","article-title":"Dysfunction of the blood-brain barrier-a key step in neurodegeneration and dementia","volume":"12","author":"Noe","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"19","key":"10.1016\/j.neuroscience.2024.12.059_b0510","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1212\/WNL.0000000000200182","article-title":"Association of statins with cerebral atherosclerosis and incident Parkinsonism in older adults","volume":"98","author":"Oveisgharan","year":"2022","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.059_b0515","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11883-020-00884-2","article-title":"The knowns and unknowns of contemporary statin therapy for familial hypercholesterolemia","volume":"22","author":"Pang","year":"2020","journal-title":"Curr. Atheroscler. Rep."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0520","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/joim.12838","article-title":"Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia","volume":"284","author":"Petek","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577109","article-title":"A challenging diagnosis of reversible \u201cvascular\u201d dementia: cerebral amyloid angiopathy-related inflammation","volume":"338","author":"Poli","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0530","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000503105","article-title":"Association between use of statin and risk of dementia: a meta-analysis of observational studies","volume":"54","author":"Poly","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0535","article-title":"Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus","volume":"69","author":"Prajjwal","year":"2023","journal-title":"Dis. Mon."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0540","doi-asserted-by":"crossref","first-page":"576","DOI":"10.2310\/JIM.0b013e318246d973","article-title":"Regulation of cerebral cholesterol metabolism in Alzheimer disease","volume":"60","author":"Reiss","year":"2012","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0545","article-title":"Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong","volume":"44","author":"Ren","year":"2024","journal-title":"Lancet Reg. Health West Pac."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010126","article-title":"Statin therapy and the development of cerebral amyloid angiopathy\u2013a rodent in vivo approach","volume":"17","author":"Reuter","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.059_b0555","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7326\/0003-4819-159-10-201311190-00007","article-title":"Statins and cognitive function: a systematic review","volume":"159","author":"Richardson","year":"2013","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0560","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1345\/aph.1Q620","article-title":"Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations","volume":"46","author":"Rojas-Fernandez","year":"2012","journal-title":"Ann. Pharmacother."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0565","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/CS20160604","article-title":"Extracellular matrix inflammation in vascular cognitive impairment and dementia","volume":"131","author":"Rosenberg","year":"2017","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0570","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s13311-021-01170-y","article-title":"Vascular Cognitive Impairment (VCI)","volume":"19","author":"Rundek","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"17","key":"10.1016\/j.neuroscience.2024.12.059_b0575","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1093\/cvr\/cvac020","article-title":"Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications","volume":"118","author":"Ruscica","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"5\u20136","key":"10.1016\/j.neuroscience.2024.12.059_b0580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000091434","article-title":"Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study","volume":"21","author":"Sachdev","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.059_b0585","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011452","article-title":"Neurovascular dysfunction and faulty amyloid beta-peptide clearance in Alzheimer disease","volume":"2","author":"Sagare","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0590","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40035-018-0110-3","article-title":"The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms","volume":"7","author":"Schultz","year":"2018","journal-title":"Transl Neurodegener."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054403","article-title":"Lipids at the nexus between cerebrovascular disease and vascular dementia: the impact of HDL-cholesterol and ceramides","volume":"24","author":"Sergi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"9364","key":"10.1016\/j.neuroscience.2024.12.059_b0600","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0605","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-024-01217-3","article-title":"Hypercholesterolemia and the increased risk of vascular dementia: a cholesterol perspective","author":"Shang","year":"2024","journal-title":"Curr. Atheroscler. Rep."},{"issue":"9346","key":"10.1016\/j.neuroscience.2024.12.059_b0610","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0615","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0317167100012701","article-title":"Biomarkers of oxidative stress in vascular dementia patients","volume":"39","author":"Shi","year":"2012","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2020.10.003","article-title":"Effects of acid and lactone forms of statins on S-warfarin 7-hydroxylation catalyzed by human liver microsomes and recombinant CYP2C9 variants (CYP2C9.1 and CYP2C9.3)","volume":"36","author":"Shiozawa","year":"2021","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0625","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109492","article-title":"Rehmannioside A attenuates cognitive deficits in rats with vascular dementia (VD) through suppressing oxidative stress, inflammation and apoptosis","volume":"120","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0635","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12967-020-02326-8","article-title":"The effects of statins on dental and oral health: a review of preclinical and clinical studies","volume":"18","author":"Tahamtan","year":"2020","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0640","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-019-0357-9","article-title":"Roles of vascular risk factors in the pathogenesis of dementia","volume":"43","author":"Takeda","year":"2020","journal-title":"Hypertens. Res."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.059_b0645","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuroscience.2024.12.059_b0650","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2638703","article-title":"Oxidative stress and dementia in Alzheimer's patients: effects of synbiotic supplementation","volume":"2020","author":"Ton","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0655","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2009.06.003","article-title":"Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice","volume":"35","author":"Tong","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"14","key":"10.1016\/j.neuroscience.2024.12.059_b0660","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1523\/JNEUROSCI.0169-12.2012","article-title":"Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits","volume":"32","author":"Tong","year":"2012","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0665","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.2009.172072","article-title":"Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis","volume":"81","author":"Topakian","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.neuroscience.2024.12.059_b0670","doi-asserted-by":"crossref","first-page":"13280","DOI":"10.1096\/fj.201901002R","article-title":"Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia","volume":"33","author":"Trigiani","year":"2019","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.059_b0675","first-page":"259","article-title":"Serum HDL, LDL and total cholesterol in patients with late-life onset of Alzheimer's disease versus vascular dementia","volume":"48","author":"Trkanjec","year":"2009","journal-title":"Acta Clin. Croat."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0680","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/neup.12262","article-title":"Blood-brain barrier damage in vascular dementia","volume":"36","author":"Ueno","year":"2016","journal-title":"Neuropathology"},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0685","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jgs.13835","article-title":"Effect of vascular risk factors and diseases on mortality in individuals with dementia: a systematic review and meta-analysis","volume":"64","author":"van de Vorst","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0690","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12974-022-02409-x","article-title":"Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis","volume":"19","author":"Vigne","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"18","key":"10.1016\/j.neuroscience.2024.12.059_b0695","first-page":"9601","article-title":"Inflammation, apoptosis and autophagy as critical players in vascular dementia","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.059_b0700","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0705","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1741-7015-5-20","article-title":"Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease","volume":"5","author":"Wolozin","year":"2007","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0710","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pds.3381","article-title":"Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding","volume":"22","author":"Wong","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0715","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3233\/JAD-191023","article-title":"Association of hypercholesterolemia with Alzheimer's disease pathology and cerebral amyloid angiopathy","volume":"73","author":"Xu","year":"2020","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.059_b0720","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3171\/2010.7.JNS10163","article-title":"Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study","volume":"114","author":"Yang","year":"2011","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.059_b0725","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4236\/jbbs.2013.31010","article-title":"Statins protect the blood brain barrier acutely after experimental intracerebral Hemorrhage","volume":"3","author":"Yang","year":"2013","journal-title":"J Behav Brain Sci."},{"key":"10.1016\/j.neuroscience.2024.12.059_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100962","article-title":"Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis","volume":"57","author":"Yang","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0735","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archpsyc.62.2.217","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study","volume":"62","author":"Zandi","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"14","key":"10.1016\/j.neuroscience.2024.12.059_b0740","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.7150\/ijbs.42965","article-title":"Pleiotropic use of Statins as non-lipid-lowering drugs","volume":"16","author":"Zhang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.059_b0745","first-page":"4695","article-title":"Puerarin attenuates cognitive dysfunction and oxidative stress in vascular dementia rats induced by chronic ischemia","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"25","key":"10.1016\/j.neuroscience.2024.12.059_b0750","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/j.jacc.2021.04.075","article-title":"Effect of statin therapy on cognitive decline and incident dementia in older adults","volume":"77","author":"Zhou","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.059_b0755","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2016.3783","article-title":"Sex and race differences in the association between statin use and the incidence of Alzheimer disease","volume":"74","author":"Zissimopoulos","year":"2017","journal-title":"JAMA Neurol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:09:24Z","timestamp":1774260564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224007723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":151,"alternative-id":["S0306452224007723"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.059","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins for vascular dementia: A hype or hope","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}